Tuesday Jul 04, 2023

Corruption at a major policy bank, and AbbVie sues an upstart drug maker

China Development Bank has become the target of the latest anti-corruption crackdown by China’s main graft buster. Will this affect China’s policy of lending big money to developing countries, and if so, what’s driving such a shift?

And AbbVie has filed a suit in the U.S. against BeiGene, one of China’s most up-and-coming young drug makers. What’s likely to happen next in this tug of war between the two companies’ similar blood cancer drugs? Exactly how expensive and destructive are such lawsuits to the companies involved?

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright Bamboo Works 2022 All rights reserved.

Podcast Powered By Podbean

Version: 20240320